The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.
ยฉ Mike Blake/Reuters
Eli Lilly company offices in San Diego. The company reported results of retatrutide, its next-generation weight-loss drug.